Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 1/20 | 0.41 |
| ▸ | PRKCI | P41743 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FADS1 | O60427 | 1/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.32 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29807239 | 1.00 | AXL (0.41) | AXLPRKCIDAOKDM4EMEN1 | |
| SCHEMBL30731217 | 0.73 | PRKCI (0.41) | PRKCIDAOKCNA3 | |
| SCHEMBL22554158 | 0.73 | PRKCI (0.41) | PRKCIDAOKCNA3 | |
| SCHEMBL22270836 | 0.73 | KCNA3 (0.32) | ALDH1A1KCNA3MAPTSMN1; SMN2 | |
| SCHEMBL14216744 | 0.73 | CDK5 (0.32) | KDM4EKCNA3 | |
| SCHEMBL899214 | 0.73 | NCF1 (0.43) | KCNA3MMP14NR4A2HSP90AA1SLC40A1 | |
| SCHEMBL12143638 | 0.73 | CCR1 (0.48) | KDM4EMEN1ALDH1A1KMT2AKCNA3 | |
| SCHEMBL8570710 | 0.72 | KCNA3 (0.33) | KCNA3 | |
| SCHEMBL1785195 | 0.71 | PDE4A (0.42) | AXLKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL25253882 | 0.68 | SLC40A1 (0.35) | AXLKCNA3SLC40A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473284-B2 | Small molecule inhibitors of ULK1 | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2025-11-18 | — | — | US | disclosed |
| US-20240150293-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | VERNALIS (R&D) LTD (GB) | 2024-05-09 | — | — | US | disclosed |
| EP-4277892-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | Les Laboratoires Servier (FR) | 2023-11-22 | — | — | EP | disclosed |
| CN-116940552-A | Spirocyclic hexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors | 法国施维雅药厂 | 2023-10-24 | — | — | CN | disclosed |
| US-20230117572-A1 | SMALL MOLECULE INHIBITORS OF ULK1 | MEMORIAL SLOAN KETTERING CANCER CENTER | 2023-04-20 | — | — | US | disclosed |
| US-20230117572-A1 | SMALL MOLECULE INHIBITORS OF ULK1 | MEMORIAL SLOAN KETTERING CANCER CENTER | 2023-04-20 | — | — | US | disclosed |
| WO-2022152705-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | LES LABORATOIRES SERVIER (FR) | 2022-07-21 | — | — | WO | disclosed |
| US-20210317134-A1 | UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF | RAPT THERAPEUTICS INC (US) | 2021-10-14 | — | — | US | disclosed |
| WO-2021138331-A2 | SMALL MOLECULE INHIBITORS OF ULK1 | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2021-07-08 | — | — | WO | disclosed |
| WO-2021138331-A2 | SMALL MOLECULE INHIBITORS OF ULK1 | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2021-07-08 | — | — | WO | disclosed |
| EP-2955185-B1 | POLYCYCLIC SUBSTITUTED PYRAZOLE KINASE ACTIVITY INHIBITORS AND USE THEREOF | SHANGHAI FOSUN PHARMACEUTICAL DEV CO LTD (CN) | 2021-01-06 | — | — | EP | disclosed |
| CN-107098903-B | Polycyclic substituted pyrazole kinase activity inhibitor and application thereof | 上海复星医药产业发展有限公司 | 2020-07-17 | — | — | CN | disclosed |
| US-9550792-B2 | Polycyclic substituted pyrazole kinase activity inhibitors and use thereof | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) | 2017-01-24 | — | — | US | disclosed |
| US-20150368259-A1 | Polycyclic Substituted Pyrazole Kinase Activity Inhibitors and Use Thereof | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) | 2015-12-24 | — | — | US | disclosed |
| EP-2955185-A1 | POLYCYCLIC SUBSTITUTED PYRAZOLE KINASE ACTIVITY INHIBITORS AND USE THEREOF | China Pharmaceutical University (CN) | 2015-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230117572-A1 | SMALL MOLECULE INHIBITORS OF ULK1 | ULK1, ULK2, ULK3 | AXL 779/4885PRKCI 1163/4885DAO 4763/4885 |
| US-20240150293-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | BCL2, BAX, BCL2A1 | AXL 4248/4885PRKCI 1765/4885DAO 4782/4885 |
| US-12473284-B2 | Small molecule inhibitors of ULK1 | ULK1, ULK2, ULK3 | AXL 779/4885PRKCI 1163/4885DAO 4763/4885 |
| US-20210317134-A1 | UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF | USP7, SENP7, USP8 | AXL 2071/4885PRKCI 1821/4885DAO 2216/4885 |
| US-20150368259-A1 | Polycyclic Substituted Pyrazole Kinase Activity Inhibitors and Use Thereof | MAP3K5, MAP3K19, MAP3K3 | AXL 413/4885PRKCI 159/4885DAO 1680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.